Cases
Cases 41 - 50 of 84
Pfizer Inc. et al. v. Cipla USA Inc. et al.
as 1:2019cv00749
Plaintiff: Pfizer Manufacturing Holdings LLC, Pfizer PFE Ireland Pharmaceuticals Holding 1 B.V., Pfizer Inc. and others
Defendant: Cipla, Ltd. and Cipla USA Inc.
Cause Of Action: 35 U.S.C. § 271
Cipla Limited et al v. AstraZeneca AB et al
as 1:2019cv00733
Defendant: AstraZeneca AB, Aktiebolaget Hassle, AstraZeneca Pharmaceuticals LP and others
Plaintiff: Cipla Limited and Cipla USA, Inc.
Cause Of Action: 35 U.S.C. § 271
Amgen Inc. v. Watson Laboratories, Inc.
as 19-1770
Defendant / Appellee: AMNEAL PHARMACEUTICALS OF NEW YORK LLC, SUN PHARMACEUTICAL INDUSTRIES, INC., CIPLA LIMITED and others
Plaintiff / Appellant: AMGEN INC.
Defendant: ACTAVIS PHARMA, INC. and WATSON LABORATORIES, INC.
In re: Kerydin (Tavaborole) Topical Solution 5% Patent Litigation
as 1:2019md02884
Counter Claimant: Glasshouse Pharmaceuticals Limited Canada
Not Classified By Court: Taro Pharmaceuticals U.S.A., Inc., Aurobindo Pharma Limited, Zydus Pharmaceuticals (USA) Inc. and others
In Re: Kerydin (Tavaborole) Topical Solution 5% Patent Litigation
Counter Defendant: Anacor Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Amgen Inc. v. Watson Laboratories, Inc.
as 19-1650
Plaintiff / Appellant: AMGEN INC.
Defendant / Appellee: ACTAVIS PHARMA, INC., WATSON LABORATORIES, INC., AMNEAL PHARMACEUTICALS OF NEW YORK LLC and others
Cipla Limited et al v. AstraZeneca AB et al
as 1:2019cv00438
Defendant: AstraZeneca AB, Aktiebolaget Hassle, AstraZeneca Pharmaceuticals LP and others
Plaintiff: Cipla Limited and Cipla USA, Inc.
Cause Of Action: 28 U.S.C. § 2201
Genentech, Inc. et al v. InvaGen Pharmaceuticals, Inc., et al.
as 1:2019cv00219
Plaintiff: Genentech, Inc. and InterMune, Inc.
Defendant: Cipla Limited, InvaGen Pharmaceuticals, Inc. and Cipla USA, Inc.
Cause Of Action: 35 U.S.C. § 271
VALEANT PHARMACEUTICALS NORTH AMERICA LLC et al v. CIPLA LTD. et al
as 3:2019cv00988
Defendant: CIPLA LTD. and CIPLA USA INC.
Plaintiff: KAKEN PHARMACEUTICAL CO., LTD., DOW PHARMACEUTICAL SCIENCES, INC., VALEANT PHARMACEUTICALS NORTH AMERICA LLC and others
Cause Of Action: 35 U.S.C. § 271
Cipla Ltd. et al v. Amgen Inc. We have downloadable decisions or orders for this case
as 1:2019cv00044
Defendant: Amgen Inc. and Teva Pharmaceuticals USA, Inc.
Plaintiff: Cipla USA, Inc. and Cipla Ltd.
Cause Of Action: 15 U.S.C. § 1
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Cipla Limited et al
as 1:2018cv01789
Defendant: Cipla USA, Inc. and Cipla Limited
Plaintiff: Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc. and Boehringer Ingelheim International GmbH
Cause Of Action: 35 U.S.C. § 271

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?